Cell and Tissue Reaction Engineering With a Contribution by Martin Fussenegger and Wilfried Weber /

The completion of the Human Genome Project and the rapid progress in cell bi- ogy and biochemical engineering, are major forces driving the steady increase of approved biotech products, especially biopharmaceuticals, in the market. Today mammalian cell products (“products from cells”), primarily mon...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Eibl, Regine (Συγγραφέας), Eibl, Dieter (Συγγραφέας), Pörtner, Ralf (Συγγραφέας), Catapano, Gerardo (Συγγραφέας), Czermak, Peter (Συγγραφέας)
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Berlin, Heidelberg : Springer Berlin Heidelberg, 2009.
Σειρά:Principles and Practice,
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
LEADER 04166nam a22006135i 4500
001 978-3-540-68182-3
003 DE-He213
005 20151204163819.0
007 cr nn 008mamaa
008 100301s2009 gw | s |||| 0|eng d
020 |a 9783540681823  |9 978-3-540-68182-3 
024 7 |a 10.1007/978-3-540-68182-3  |2 doi 
040 |d GrThAP 
050 4 |a QH585.2-.45 
072 7 |a PSF  |2 bicssc 
072 7 |a SCI017000  |2 bisacsh 
072 7 |a SCI049000  |2 bisacsh 
082 0 4 |a 571.638  |2 23 
100 1 |a Eibl, Regine.  |e author. 
245 1 0 |a Cell and Tissue Reaction Engineering  |h [electronic resource] :  |b With a Contribution by Martin Fussenegger and Wilfried Weber /  |c by Regine Eibl, Dieter Eibl, Ralf Pörtner, Gerardo Catapano, Peter Czermak. 
264 1 |a Berlin, Heidelberg :  |b Springer Berlin Heidelberg,  |c 2009. 
300 |a XI, 363 p.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
490 1 |a Principles and Practice,  |x 1866-914X 
505 0 |a Mammalian Cells -- Mammalian Cell Culture Technology: An Emerging Field -- Characteristics of Mammalian Cells and Requirements for Cultivation -- Bioreactors for Mammalian Cells: General Overview -- Special Engineering Aspects -- Bioreactor Design and Scale-Up -- Special Applications -- Insect Cell-Based Recombinant Protein Production -- Bioreactors for Bioartificial Organs -- Plant Cell-Based Bioprocessing. 
520 |a The completion of the Human Genome Project and the rapid progress in cell bi- ogy and biochemical engineering, are major forces driving the steady increase of approved biotech products, especially biopharmaceuticals, in the market. Today mammalian cell products (“products from cells”), primarily monoclonals, cytokines, recombinant glycoproteins, and, increasingly, vaccines, dominate the biopharmaceutical industry. Moreover, a small number of products consisting of in vitro cultivated cells (“cells as product”) for regenerative medicine have also been introduced in the market. Their efficient production requires comprehensive knowledge of biological as well as biochemical mammalian cell culture fundamentals (e.g., cell characteristics and metabolism, cell line establishment, culture medium optimization) and related engineering principles (e.g., bioreactor design, process scale-up and optimization). In addition, new developments focusing on cell line development, animal-free c- ture media, disposables and the implications of changing processes (multi-purpo- facilities) have to be taken into account. While a number of excellent books treating the basic methods and applications of mammalian cell culture technology have been published, only little attention has been afforded to their engineering aspects. The aim of this book is to make a contribution to closing this gap; it particularly focuses on the interactions between biological and biochemical and engineering principles in processes derived from cell cultures. It is not intended to give a c- prehensive overview of the literature. This has been done extensively elsewhere. 
650 0 |a Life sciences. 
650 0 |a Pharmaceutical technology. 
650 0 |a Biotechnology. 
650 0 |a Biochemical engineering. 
650 0 |a Cell biology. 
650 0 |a Cell culture. 
650 0 |a Biomedical engineering. 
650 1 4 |a Life Sciences. 
650 2 4 |a Cell Culture. 
650 2 4 |a Biochemical Engineering. 
650 2 4 |a Biomedical Engineering. 
650 2 4 |a Pharmaceutical Sciences/Technology. 
650 2 4 |a Cell Biology. 
650 2 4 |a Biotechnology. 
700 1 |a Eibl, Dieter.  |e author. 
700 1 |a Pörtner, Ralf.  |e author. 
700 1 |a Catapano, Gerardo.  |e author. 
700 1 |a Czermak, Peter.  |e author. 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
776 0 8 |i Printed edition:  |z 9783540681755 
830 0 |a Principles and Practice,  |x 1866-914X 
856 4 0 |u http://dx.doi.org/10.1007/978-3-540-68182-3  |z Full Text via HEAL-Link 
912 |a ZDB-2-SBL 
950 |a Biomedical and Life Sciences (Springer-11642)